New reports on pension funds!

Get basic information about any company in Switzerland (including auditor information).

Santhera Pharmaceuticals Holding AG

Core Company Information
Company Name Santhera Pharmaceuticals Holding AG
UID CHE-105.388.338
CH-ID CH-270.3.012.442-0
Domicile Pratteln (BL)
Legal Form Limited corporation
Capital (nominal / paid up) CHF 1'255'884 / CHF 1'255'884 (registered shares)
Status active
Firm Inscription Date 26.01.2000
Accounting standard IFRS
Previous names Santhera Pharmaceuticals AG, Santhera Pharmaceuticals SA, Santhera Pharmaceuticals Ltd (until 04.05.2006)
MyoContract AG, MyoContract Ltd, MyoContract SA (until 16.07.2002)
MyoContract Pharmaceutical Research AG, MyoContract Pharmaceutical Research Ltd, MyoContract Pharmaceutical Research SA (until 16.07.2002)
Previous domiciles
(in other cantons)		 Basel (BS), bis 26.07.2002
Address and Contact Details
Address Hohenrainstrasse 24
4133 Pratteln
   
Listing Information

The shares of this company are listed on a public stock exchange.

Stock exchange SIX Swiss Exchange
Primary listing Yes
Segment International Reporting Standard
   
Symbol SANN
Valor number 2714864
ISIN CH0027148649
Index member SPI
Listed since 03.11.2006

For a more detailed analysis of the Swiss audit market for listed companies we recommend that you check out the annual Swiss Audit Monitor.
Outstanding bonds (only SIX)
7.50 SANPHAR CV 21-24
Symbol SAN21
ISIN / Valor number   CH0563348744 / 56334874
Coupon 7.5000%
Face value CHF 30'270'375
Term 04.05.2021 - 19.08.2024
Type of bond Convertible bond
   
Current Statutory Auditor
Auditor Name Ernst & Young AG
Auditor UID (Branch) CHE-105.932.265
Auditor Place (Branch) Basel
Auditor UID (Head Office) CHE-105.932.265
Auditor RAB-ID 500646
Auditor Permission Type state-regulated audit firm
FAOA License active
Link to FAOA website View auditor profile at FAOA
Auditor Overall Status OK

Extract last processed on: 30.06.2023 18:40:19, Last Update of Non-Auditor Information: 30.06.2023 18:40:13